{
"id":"mk19_bb_pm_s12",
"subspecialtyId":"pm",
"title":"Pulmonary Hypertension",
"jsonContent":{
"type":"section",
"id":"mk19_bb_pm_s12",
"title":{
"__html":"Pulmonary Hypertension"
},
"titleNode":{
"type":"section-title",
"hlId":"c0fd61",
"children":[
"Pulmonary Hypertension"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_pm_s12_1",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"c22cdc",
"children":[
{
"type":"abbreviation",
"title":"pulmonary hypertension",
"children":[
"PH"
]
},
" is defined by a resting mean pulmonary arterial pressure of ≥20 mm Hg and a pulmonary capillary wedge pressure ≤15 mm Hg. The current classification system subdivides PH into five groups."
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"fa8094",
"children":[
"Group 1 is distinguished by disease localized to small pulmonary arterioles resulting in high pulmonary vascular resistance and is referred to as ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"pulmonary arterial hypertension",
"children":[
"PAH"
]
},
"."
]
}
]
},
" ",
{
"type":"list-item",
"hlId":"95d6b4",
"children":[
"Groups 2 through 5 refer to important secondary causes of PH and include left-sided heart disease, respiratory disorders (",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"chronic obstructive pulmonary disease",
"children":[
"COPD"
]
},
","
]
},
" interstitial lung disease, and sleep-disordered breathing), and chronic venous thromboembolic disease."
]
},
" "
]
},
{
"type":"p",
"hlId":"5bbd54",
"children":[
"Characteristic symptoms of PH include:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"94b7dd",
"children":[
"unexplained dyspnea"
]
},
" ",
{
"type":"list-item",
"hlId":"2cbac9",
"children":[
"decreased exercise tolerance"
]
},
" ",
{
"type":"list-item",
"hlId":"8d5fa4",
"children":[
"syncope and near-syncope"
]
},
" ",
{
"type":"list-item",
"hlId":"27a038",
"children":[
"chest pain"
]
},
" ",
{
"type":"list-item",
"hlId":"e6691d",
"children":[
"lower extremity edema"
]
},
" "
]
},
{
"type":"p",
"hlId":"2e9d5a",
"children":[
"Physical examination findings indicating ",
{
"type":"abbreviation",
"title":"right ventricular",
"children":[
"RV"
]
},
" failure may include an RV heave, right-sided S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"3"
]
},
", widely split S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
", increased P",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
", increased jugular venous distention with a large ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"a"
]
},
" wave, and a murmur of ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"tricuspid regurgitation",
"children":[
"TR"
]
},
"."
]
}
]
},
{
"type":"p",
"hlId":"99c1e1",
"children":[
"Look for use of fenfluramine, amphetamines, and cocaine, as well as the presence of Raynaud phenomenon (suggesting ",
{
"type":"abbreviation",
"title":"systemic lupus erythematosus",
"children":[
"SLE"
]
},
" and ",
{
"type":"abbreviation",
"title":"systemic sclerosis",
"children":[
"SSc"
]
},
") and history of ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"venous thromboembolism",
"children":[
"VTE"
]
},
"."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_bb_pm_s12_2",
"title":{
"__html":"Testing"
},
"titleNode":{
"type":"section-title",
"hlId":"fa6a5a",
"children":[
"Testing"
]
},
"children":[
{
"type":"p",
"hlId":"48fe6a",
"children":[
"Typical evaluation of Group 1 PH (PAH) includes:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"450315",
"children":[
"echocardiography as the initial study"
]
},
" ",
{
"type":"list-item",
"hlId":"d5dbc6",
"children":[
"right heart catheterization to confirm the diagnosis and quantify the degree of PH"
]
},
" ",
{
"type":"list-item",
"hlId":"65d3f7",
"children":[
"left heart catheterization and coronary angiography exclude ",
{
"type":"abbreviation",
"title":"left ventricular",
"children":[
"LV"
]
},
" dysfunction as a cause of PH"
]
},
" "
]
},
{
"type":"p",
"hlId":"555348",
"children":[
"If the diagnosis of PAH is confirmed, the next step is a vasoreactivity test using vasodilating agents to measure changes in pulmonary artery pressure with a right heart catheter in place."
]
},
{
"type":"p",
"hlId":"70cb2b",
"children":[
"Additional recommended tests to rule out other causes of PH include ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"pulmonary function test",
"children":[
"PFT"
]
},
"s,"
]
},
" ",
{
"type":"abbreviation",
"title":"high-resolution computed tomography",
"children":[
"HRCT"
]
},
" (if considering interstitial lung disease), liver function tests, polysomnography if clinically indicated, and serologic tests for HIV infection or connective tissue disease."
]
},
{
"type":"p",
"hlId":"c9953a",
"children":[
"In some patients (<5%) after an acute ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"pulmonary embolism",
"children":[
"PE"
]
},
","
]
},
" thromboemboli within the pulmonary arteries become remodeled into large occlusive scars, causing ",
{
"type":"abbreviation",
"title":"chronic thromboembolic pulmonary hypertension",
"children":[
"CTEPH"
]
},
" and leading to right-sided ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"heart failure",
"children":[
"HF"
]
},
"."
]
}
]
},
{
"type":"p",
"hlId":"f56321",
"children":[
"Two diagnostic criteria for CTEPH:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"4202ea",
"children":[
"pulmonary artery pressure ≥20 mm Hg in the absence of left-sided HF"
]
},
" ",
{
"type":"list-item",
"hlId":"026d94",
"children":[
"compatible imaging evidence of chronic thromboembolism by ",
{
"type":"abbreviation",
"title":"ventilation/perfusion ratio",
"children":[
"V/Q"
]
},
" scanning"
]
},
" "
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"89c727",
"children":[
"Most cases of PH are attributed to left-sided heart disease and hypoxic respiratory disorders."
]
},
" ",
{
"type":"list-item",
"hlId":"afe8de",
"children":[
"Do not select ",
{
"type":"abbreviation",
"title":"computed tomography angiography",
"children":[
"CTA"
]
},
" to diagnose CTEPH. A V/Q scan is superior."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_pm_s12_3",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"3bd2c2",
"children":[
"Therapy for PH groups 2 through 5 is typically directed at the underlying condition."
]
},
{
"type":"p",
"hlId":"5b0739",
"children":[
"For Group 1 PH (PAH), vascular-targeted treatments provide symptomatic relief but are not curative."
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"6e0c8f",
"children":[
"Calcium channel blockers are used for patients demonstrating a vasodilator response on right heart catheterization."
]
},
" ",
{
"type":"list-item",
"hlId":"e8bdf6",
"children":[
"Combination therapy with ambrisentan (prostacyclin analogue) and tadalafil (",
{
"type":"abbreviation",
"title":"phosphodiesterase type 5",
"children":[
"PDE-5"
]
},
" inhibitor) is the recommended first-line therapy if the patient is willing and able to tolerate it. Lung or heart-lung transplantation should be considered for patients in whom drug treatment is unsuccessful."
]
},
" ",
{
"type":"list-item",
"hlId":"ed6262",
"children":[
"Oxygen therapy is indicated for O",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" saturation ≤90%."
]
},
" "
]
},
{
"type":"p",
"hlId":"b89c78",
"children":[
"Life-long anticoagulant therapy is indicated in all patients with CTEPH. Pulmonary thromboendarterectomy is the only definitive therapy for CTEPH."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"daf266",
"children":[
"Do not select calcium channel blockers if pulmonary artery pressure is not decreased with a vasoreactivity test."
]
},
" "
]
}
]
}
]
},
"tablesContent":{
}
}